Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (새로운 창 열기)

Abd Hamid IJ, M Iyen MI, Ibrahim NR, Abd Majid N, Ramli N, Van Rostenberghe H.

Source‎: J Paediatr Child Health 2013;49(5):375-9.

Indexed‎: PubMed 23573836

DOI‎: 10.1111/jpc.12192

https://www.ncbi.nlm.nih.gov/pubmed/23573836 (새로운 창 열기)

Effect of white plastic cover around the phototherapy unit on hyperbilirubinemia in full term neonates. (새로운 창 열기)

Babaei H, Alipour AA, Hemmati M, Ghaderi M, Rezaei M.

Source‎: Iran J Pediatr 2013;23(2):143-8.

Indexed‎: PubMed 23724173

https://www.ncbi.nlm.nih.gov/pubmed/23724173 (새로운 창 열기)

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (새로운 창 열기)

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Source‎: Pediatrics 2011;128(4):e1046-52.

Indexed‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

https://www.ncbi.nlm.nih.gov/pubmed/21949150 (새로운 창 열기)

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (새로운 창 열기)

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Source‎: Acta Paediatr 2011;100(4):620-3.

Indexed‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

https://www.ncbi.nlm.nih.gov/pubmed/21251060 (새로운 창 열기)

Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (새로운 창 열기)

Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZ, Hansen TW, Van Rostenberghe H.

Source‎: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.

Indexed‎: PubMed 16877479

DOI‎: 10.1136/adc.2006.095687

https://www.ncbi.nlm.nih.gov/pubmed/16877479 (새로운 창 열기)

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (새로운 창 열기)

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Source‎: Cochrane Database Syst Rev 2012;(12):CD009017.

Indexed‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23235669 (새로운 창 열기)

Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (새로운 창 열기)

Kumar P, Chawla D, Deorari A.

Source‎: Cochrane Database Syst Rev 2011;(12):CD007969.

Indexed‎: PubMed 22161417

DOI‎: 10.1002/14651858.CD007969.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22161417 (새로운 창 열기)

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (새로운 창 열기)

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Source‎: J Perinatol 2013;33(2):126-33.

Indexed‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

https://www.ncbi.nlm.nih.gov/pubmed/22499082 (새로운 창 열기)

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (새로운 창 열기)

Okwundu CI, Okoromah CA, Shah PS.

Source‎: Cochrane Database Syst Rev 2012;(1):CD007966.

Indexed‎: PubMed 22258977

DOI‎: 10.1002/14651858.CD007966.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22258977 (새로운 창 열기)

The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (새로운 창 열기)

Sakha SH, Gharehbaghi MM, Rahbani ME.

Source‎: Indian J Med Sci 2009;63(5):174-9.

Indexed‎: PubMed 19584487

DOI‎: 10.4103/0019-5359.53162

https://www.ncbi.nlm.nih.gov/pubmed/19584487 (새로운 창 열기)

A randomized trial of phototherapy with filtered sunlight in African neonates. (새로운 창 열기)

Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK.

Source‎: N Engl J Med 2015;373(12):1115-24.

Indexed‎: PubMed 26376136

DOI‎: 10.1056/NEJMoa1501074

https://www.ncbi.nlm.nih.gov/pubmed/26376136 (새로운 창 열기)

Dose-response relationship of phototherapy for hyperbilirubinemia. (새로운 창 열기)

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Source‎: Pediatrics 2012;130(2):e352-7.

Indexed‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

https://www.ncbi.nlm.nih.gov/pubmed/22802603 (새로운 창 열기)

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (새로운 창 열기)

Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E.

Source‎: Acta Paediatr 1999;88(2):216-9.

Indexed‎: PubMed 10102158

https://www.ncbi.nlm.nih.gov/pubmed/10102158 (새로운 창 열기)

High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (새로운 창 열기)

Dağoğlu T, Ovali F, Samanci N, Bengisu E.

Source‎: J Int Med Res 1995;23(4):264-71.

Indexed‎: PubMed 7589769

DOI‎: 10.1177/030006059502300406

https://www.ncbi.nlm.nih.gov/pubmed/7589769 (새로운 창 열기)

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. (새로운 창 열기)

Gottstein R, Cooke RW.

Source‎: Arch Dis Child Fetal Neonatal Ed 2003;88(1):F6-10.

Indexed‎: PubMed 12496219

https://www.ncbi.nlm.nih.gov/pubmed/12496219 (새로운 창 열기)

Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. (새로운 창 열기)

Hammerman C, Kaplan M, Vreman HJ, Stevenson DK.

Source‎: Biol Neonate 1996;70(2):69-74.

Indexed‎: PubMed 8864425

https://www.ncbi.nlm.nih.gov/pubmed/8864425 (새로운 창 열기)

Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (새로운 창 열기)

Huizing K, Røislien J, Hansen T.

Source‎: Acta Paediatr 2008;97(10):1362-5.

Indexed‎: PubMed 18616629

DOI‎: 10.1111/j.1651-2227.2008.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/18616629 (새로운 창 열기)

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (새로운 창 열기)

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

Source‎: J Matern Fetal Neonatal Med 2004;16(3):163-6.

Indexed‎: PubMed 15590442

DOI‎: 10.1080/14767050400009873

https://www.ncbi.nlm.nih.gov/pubmed/15590442 (새로운 창 열기)

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (새로운 창 열기)

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

Source‎: J Perinatol 2016;36(7):533-9.

Indexed‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

https://www.ncbi.nlm.nih.gov/pubmed/26938918 (새로운 창 열기)

Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. (새로운 창 열기)

Kappas A, Drummond GS, Munson DP, Marshall JR.

Source‎: Pediatrics 2001;108(6):1374-7.

Indexed‎: PubMed 11731664

https://www.ncbi.nlm.nih.gov/pubmed/11731664 (새로운 창 열기)

A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. (새로운 창 열기)

Kappas A.

Source‎: Pediatrics 2004;113(1 Pt 1):119-23.

Indexed‎: PubMed 14702459

https://www.ncbi.nlm.nih.gov/pubmed/14702459 (새로운 창 열기)

Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (새로운 창 열기)

Reddy P, Najundaswamy S, Mehta R, Petrova A, Hegyi T.

Source‎: J Perinatol 2003;23(6):507-8.

Indexed‎: PubMed 13679941

DOI‎: 10.1038/sj.jp.7210943

https://www.ncbi.nlm.nih.gov/pubmed/13679941 (새로운 창 열기)

Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis. (새로운 창 열기)

Chawla D, Parmar V.

Source‎: Indian Pediatr 2010;47(5):401-7.

Indexed‎: PubMed 19736369

https://www.ncbi.nlm.nih.gov/pubmed/19736369 (새로운 창 열기)

Single dose of 50 mg/kg clofibrate in jaundice of healthy term neonates: randomised clinical trial of efficacy and safety. (새로운 창 열기)

Fallah R, Islami Z, Lotfi SR.

Source‎: Indian J Pediatr 2012;79(2):194-7.

Indexed‎: PubMed 21785863

DOI‎: 10.1007/s12098-011-0531-9

https://www.ncbi.nlm.nih.gov/pubmed/21785863 (새로운 창 열기)

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (새로운 창 열기)

Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S.

Source‎: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.

Indexed‎: PubMed 26020375

DOI‎: 10.1097/MPG.0000000000000874

https://www.ncbi.nlm.nih.gov/pubmed/26020375 (새로운 창 열기)

Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (새로운 창 열기)

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF.

Source‎: Pediatrics 2009;124(4):1193-8.

Indexed‎: PubMed 19786452

DOI‎: 10.1542/peds.2009-0329

https://www.ncbi.nlm.nih.gov/pubmed/19786452 (새로운 창 열기)

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (새로운 창 열기)

Mehta S, Kumar P, Narang A.

Source‎: J Pediatr 2005;147(6):781-5.

Indexed‎: PubMed 16356431

DOI‎: 10.1016/j.jpeds.2005.07.026

https://www.ncbi.nlm.nih.gov/pubmed/16356431 (새로운 창 열기)

Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (새로운 창 열기)

Mohammadzadeh A, Farhat AS, Amiri R, Esmaely H, Bagheri S.

Source‎: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.

Indexed‎: EMBASE 2009472903

http://www.uhod.org/summary_en.php3?id=359 (새로운 창 열기)

Clofibrate for unconjugated hyperbilirubinemia in neonates: a systematic review. (새로운 창 열기)

Xiong T, Chen D, Duan Z, Qu Y, Mu D.

Source‎: Indian Pediatr 2012;49(1):35-41.

Indexed‎: PubMed 22318100

https://www.ncbi.nlm.nih.gov/pubmed/22318100 (새로운 창 열기)

Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. (새로운 창 열기)

Yaser A, Tooke L, Rhoda N.

Source‎: J Perinatol 2014;34(3):209-12.

Indexed‎: PubMed 24406742

DOI‎: 10.1038/jp.2013.167

https://www.ncbi.nlm.nih.gov/pubmed/24406742 (새로운 창 열기)

Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (새로운 창 열기)

Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA.

Source‎: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.

Indexed‎: PubMed 18564698

https://www.ncbi.nlm.nih.gov/pubmed/18564698 (새로운 창 열기)